News US regulator grants $23 million to rare disease R&D FDA announces 21 rare disease clinical trial research grants.
News US and EU regulators collaborate on rare diseases Clinical trial design among areas regulators will collaborate on
News Biomarker trial to show drug value in rare lung disease Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.
News Vertex hit by phase 3 cystic fibrosis failure Company looks to other CF sub-groups to yield success
Views & Analysis Meeting the challenges of rare disease treatment adherence HCPs, pharma and patients can pool their experience to develop effective, tailored support.
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
